Samrucin 10mg Injection
Marketer
Cellcys Labs Private Limited
Salt Composition
Doxorubicin (Plain) (10mg)
Overview Samrucin 10mg Injection
Oncaspar 10mg Injection treats various hematologic malignancies, including breast, lung, ovarian, and soft tissue cancers. Administered intravenously by a healthcare professional, it may be used alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial, as incorrect usage can lead to severe adverse events. Therapeutic benefits may take weeks or months to manifest; discontinue use only under medical supervision. This medication can compromise contraceptive efficacy, necessitating reliable birth control for both partners during treatment. Common side effects include nausea, vomiting, allergic reactions, mucositis, and alopecia. Report any concerning symptoms to your doctor; management strategies are available. Samrucin reduces blood cell counts, increasing infection risk, potentially life-threatening. Regular blood tests are essential to monitor blood cell levels, renal, hepatic, and cardiac function. Prior to treatment, disclose any pre-existing severe liver or heart conditions, pregnancy, breastfeeding, or other medications you're taking, as interactions may affect efficacy or alter the drug's action.
Uses of Samrucin 10mg Injection
Malignant neoplasm
Major Benefits of Samrucin 10mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Samrucin 10mg Injection:
- Vomiting
- Allergic reaction
- Nausea
- Mouth sore
- Hair loss
- Stomach pain
- Eye disorder
- Increased thirst
- Arrhythmia (irregular heartbeats)
- Nail disorder
How to use Samrucin 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Samrucin 10mg Injection works:
Samrucin 10mg Injection is an antineoplastic agent that targets cancer cell proliferation. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme in DNA replication. The drug also generates cytotoxic free radicals, inducing DNA damage. This dual action impedes cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Samrucin 10mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Samrucin 10mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might deem the potential benefits outweigh the risks, justifying its use. Always seek medical advice.
Breast feedingUNSAFE
Administration of Samrucin 10mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.
DrivingUNSAFE
The use of Samrucin 10mg Injection may induce adverse reactions that impair driving ability. Given the common occurrence of nausea and vomiting following administration, operating a vehicle is strongly advised against.
KidneySAFE IF PRESCRIBED
Samrucin 10mg Injection poses no known safety risk for individuals with kidney impairment; dosage modification isn't typically necessary. Nevertheless, disclosure of any renal condition to your physician is advised.
LiverCAUTION
Individuals with hepatic impairment should use Samrucin 10mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Samrucin 10mg Injection :
NA
Facts to Know About Samrucin 10mg Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently